Guo Q, Zhao Z, Wang W, Hu X, Hu H, Hu Y
Schizophr Res Cogn. 2025; 40:100344.
PMID: 39867752
PMC: 11764624.
DOI: 10.1016/j.scog.2025.100344.
Faes L, Zulfiqar I, Vizioli L, Yu Z, Wu Y, Shin J
bioRxiv. 2025; .
PMID: 39829870
PMC: 11741426.
DOI: 10.1101/2025.01.09.632099.
Javitt D
Adv Neurobiol. 2024; 40:411-451.
PMID: 39562453
DOI: 10.1007/978-3-031-69491-2_15.
OConnell M, Barczak A
Adv Neurobiol. 2024; 40:219-234.
PMID: 39562447
DOI: 10.1007/978-3-031-69491-2_9.
Wilde M, Poulsen R, Qin W, Arnold J, Favre-Bulle I, Mattingley J
bioRxiv. 2024; .
PMID: 38915708
PMC: 11195219.
DOI: 10.1101/2024.06.14.597058.
Mechanism of an Intrinsic Oscillation in Rat Geniculate Interneurons.
Griffith E, Elsayed M, Dura-Bernal S, Neymotin S, Uhlrich D, Lytton W
bioRxiv. 2024; .
PMID: 38895250
PMC: 11185623.
DOI: 10.1101/2024.06.06.597830.
Change detection in the primate auditory cortex through feedback of prediction error signals.
Obara K, Ebina T, Terada S, Uka T, Komatsu M, Takaji M
Nat Commun. 2023; 14(1):6981.
PMID: 37957168
PMC: 10643402.
DOI: 10.1038/s41467-023-42553-3.
The Thalamocortical Mechanism Underlying the Generation and Regulation of the Auditory Steady-State Responses in Awake Mice.
Li J, Li Z, Wang X, Liu Y, Wang S, Wang X
J Neurosci. 2023; 44(1).
PMID: 37945348
PMC: 10851679.
DOI: 10.1523/JNEUROSCI.1166-23.2023.
Data-driven multiscale model of macaque auditory thalamocortical circuits reproduces in vivo dynamics.
Dura-Bernal S, Griffith E, Barczak A, OConnell M, McGinnis T, Moreira J
Cell Rep. 2023; 42(11):113378.
PMID: 37925640
PMC: 10727489.
DOI: 10.1016/j.celrep.2023.113378.
Is source-resolved magnetoencephalographic mismatch negativity a viable biomarker for early psychosis?.
Lopez-Caballero F, Curtis M, Coffman B, Salisbury D
Eur J Neurosci. 2023; 59(8):1889-1906.
PMID: 37537883
PMC: 10837325.
DOI: 10.1111/ejn.16107.
Omission responses in local field potentials in rat auditory cortex.
Auksztulewicz R, Rajendran V, Peng F, Schnupp J, Harper N
BMC Biol. 2023; 21(1):130.
PMID: 37254137
PMC: 10230691.
DOI: 10.1186/s12915-023-01592-4.
Early auditory processing dysfunction in schizophrenia: Mechanisms and implications.
Donde C, Kantrowitz J, Medalia A, Saperstein A, Balla A, Sehatpour P
Neurosci Biobehav Rev. 2023; 148:105098.
PMID: 36796472
PMC: 10106448.
DOI: 10.1016/j.neubiorev.2023.105098.
Detecting Spontaneous Neural Oscillation Events in Primate Auditory Cortex.
Neymotin S, Tal I, Barczak A, OConnell M, McGinnis T, Markowitz N
eNeuro. 2022; 9(4).
PMID: 35906065
PMC: 9395248.
DOI: 10.1523/ENEURO.0281-21.2022.
Automatic auditory processing features in distinct subtypes of patients at clinical high risk for psychosis: Forecasting remission with mismatch negativity.
Wu G, Tang X, Gan R, Zeng J, Hu Y, Xu L
Hum Brain Mapp. 2022; 43(18):5452-5464.
PMID: 35848373
PMC: 9704791.
DOI: 10.1002/hbm.26021.
Non-rapid eye movement sleep and wake neurophysiology in schizophrenia.
Kozhemiako N, Wang J, Jiang C, Wang L, Gai G, Zou K
Elife. 2022; 11.
PMID: 35578829
PMC: 9113745.
DOI: 10.7554/eLife.76211.
Neocortical localization and thalamocortical modulation of neuronal hyperexcitability contribute to Fragile X Syndrome.
Pedapati E, Schmitt L, Ethridge L, Miyakoshi M, Sweeney J, Liu R
Commun Biol. 2022; 5(1):442.
PMID: 35546357
PMC: 9095835.
DOI: 10.1038/s42003-022-03395-9.
Constructing the hierarchy of predictive auditory sequences in the marmoset brain.
Jiang Y, Komatsu M, Chen Y, Xie R, Zhang K, Xia Y
Elife. 2022; 11.
PMID: 35174784
PMC: 8893719.
DOI: 10.7554/eLife.74653.
mGluR5 binding changes during a mismatch negativity task in a multimodal protocol with [C]ABP688 PET/MR-EEG.
Regio Brambilla C, Veselinovic T, Rajkumar R, Mauler J, Matusch A, Ruch A
Transl Psychiatry. 2022; 12(1):6.
PMID: 35013095
PMC: 8748790.
DOI: 10.1038/s41398-021-01763-3.
Irreversible specialization for speech perception in early international adoptees.
Norrman G, Bylund E, Thierry G
Cereb Cortex. 2021; 32(17):3777-3785.
PMID: 34952538
PMC: 9433419.
DOI: 10.1093/cercor/bhab447.
Mismatch negativity as an index of target engagement for excitation/inhibition-based treatment development: a double-blind, placebo-controlled, randomized, single-dose cross-over study of the serotonin type-3 receptor antagonist CVN058.
Sehatpour P, Javitt D, De Baun H, Carlson M, Beloborodova A, Margolin D
Neuropsychopharmacology. 2021; 47(3):711-718.
PMID: 34667294
PMC: 8782925.
DOI: 10.1038/s41386-021-01170-8.